AstraZeneca Pharma reports net loss of Rs 17.70 crore in Q3

06 Feb 2013 Evaluate

AstraZeneca Pharma India has reported results for third quarter ended December 31, 2012.

The company has reported a net loss of Rs 17.70 crore for the quarter as compared to a net profit of Rs 14.94 crore for the same quarter in the previous year. Total income of the company has decreased by 32.15% at Rs 105.16 crore for quarter under review as compared to Rs 154.99 crore for the quarter ended December 31, 2011.

AstraZeneca operates through two entities, AstraZeneca Pharma India and AstraZeneca India in the country.

Astrazeneca Pharma I Share Price

8728.45 -233.50 (-2.61%)
25-Apr-2025 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1786.85
Dr. Reddys Lab 1173.55
Cipla 1525.50
Lupin 2018.35
Zydus Lifesciences 859.10
View more..
© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.
×
Please wait your portfolio is updating...